Categories: News

Fulcrum Therapeutics™ to Host Third Quarter 2021 Financial Results Conference Call and Webcast on Thursday, November 4, 2021 at 8:00 a.m. ET

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its third quarter 2021 financial results will be released on Thursday, November 4, 2021 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.

Dial-in Number
U.S./Canada Dial-in Number: 800-527-6973
International Dial-in Number: 470-495-9162
Conference ID: 7525705

Replay Dial-in Number: 855-859-2056
Replay International Dial-in Number: 404-537-3406
Conference ID: 7525705

An audio webcast will be accessible through the Investor Relations section of the company’s website https://ir.fulcrumtx.com/events-and-presentations. Following the live webcast, an archived replay will also be available.

About Fulcrum Therapeutics 
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum’s proprietary product engine, FulcrumSeek™, identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. Fulcrum has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral muscular dystrophy (FSHD). Fulcrum has also advanced FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and beta-thalassemia into Phase 1 clinical development.

Please visit www.fulcrumtx.com.

Contact:
Naomi Aoki
Senior Vice President,
Corporate Communications and Investor Relations
naoki@fulcrumtx.com

Staff

Recent Posts

PhantomOmics and Garden Loft Partner to Launch World’s First Smart Modular Senior Homes with Embedded Health Scanning Technology

Calgary, Alberta--(Newsfile Corp. - August 7, 2025) -  Two Alberta innovators, PhantomOmics Inc. and Garden…

18 minutes ago

SurgiBox Achieves CE Mark for SurgiField System Devices to Improve Access to Safe Surgery at the Point of Need

CE Certification positions SurgiBox for global expansion and robust sales acceleration CAMBRIDGE, Mass., Aug. 7,…

1 hour ago

Atlanta Facial Plastic Surgeon and Bitcoin Advocate Dr. Benjamin Stong Featured on The Bitcoin Fellowship Show

Headline Summary: Dr. Benjamin Stong, founder of Kalos Facial Plastic Surgery in Atlanta, was recently…

1 hour ago

Healthcare Outcomes Performance Company acquires Caro Health to advance AI-powered healthcare innovation and accelerate global growth

Acquisition integrates advanced AI-driven patient engagement and operational tools into HOPCo's expanding digital health and…

1 hour ago

Why Health Literacy for Kids Matters: How Know Yourself Academy Helps Children Learn About Their Bodies, Health Habits, and Wellness

SANTA BARBARA, Calif., Aug. 7, 2025 /PRNewswire/ -- Every day, parents remind their kids: brush…

1 hour ago